Affymax
Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. visit www.affymax.com

AMAG Pharmaceuticals
AMAG Pharmaceuticals is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.  Visit www.amagpharma.com for more information.

American Regent, Inc.
American Regent continues its commitment to the renal community with quality services provided by a highly trained and knowledgeable field sales force and a clinical support team of nephrology specialists focused on issues impacting pre-dialysis, hemodialysis, and peritoneal dialysis patients. Some of these services include: Facility Based In-Services and CE Presentations, Facility Based Iron Utilization Reviews, Patient Education Programs, Professional Speakers Bureau, Patient Assistance Program, a Reimbursement Hotline, a Resource Center for Clinical Inquiries, and Regional Iron and Anemia Workshops. For additional information, visit our websites at www.americanregent.com and www.venofer.com.

Amgen, Inc.
Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Astellas Pharma, Inc
Astellas and its affiliated US entities, subsidiaries of Tokyo-based Astellas Pharma, Inc., are a research-based pharmaceutical company dedicated to improving the health of people around the world through innovative pharmaceutical products. Astellas has been dedicated to the field of immunology for nearly twenty years and is the leader in transplantation. Astellas ranks among the top 20 pharmaceutical companies in the world and will continue to grow as a competitive company in the world pharmaceutical market. For more information on Astellas, please go to www.astellas.com/us or www.transplantexperience.com.

DaVita
DaVita provides dialysis services for those diagnosed with chronic kidney failure, a condition also known as chronic kidney disease (CKD). We have over 1,500 outpatient dialysis facilities and acute units in over 700 hospitals. We are located in 43 states and the District of Columbia, serving approximately 115,000 patients.
The name DaVita is an adaptation of an Italian phrase meaning, “giving life.” Everyday, in all of our clinics, we believe our name reflects our purpose.  Please learn more by visiting www.davita.com.

Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the nation’s leading integrated provider of products and services for individuals with chronic kidney failure, a condition that affects nearly 400,000 Americans, and more than 1,400,000 individuals worldwide. With more than 35,000 employees, FMCNA operates a nationwide network of clinics that provide dialysis treatment. The company also manufactures and distributes dialysis products, performs specialized diagnostic and laboratory testing for renal patients, and provides comprehensive renal disease management services. With corporate offices in Massachusetts, the company is the largest affiliate of German-based Fresenius Medical Care AG, which is in turn the world’s largest provider of products and services for individuals with chronic renal failure. The roots of the company’s Fresenius Medical Services division stem back to1970 when the company opened one of the first outpatient dialysis clinics in the world, in Boston. This was the advent of the availability of dialysis services outside of the cost and space limitations of the hospital environment and has led to more widespread access to this life-sustaining treatment nationwide.  Visit www.ultracare-dialysis.com or www.kidneyoptions.com for more information.

Genzyme
Genzyme, a global health care company, delivers innovative biotechnology products and services in therapeutics, surgery and diagnostic areas.  Genzyme is the manufacturer of Renvela® (sevelamer carbonate), Renagel® (sevelamer hydrochloride), and Hectorol® (doxercalciferol).  Genzyme is a leader in health care awareness and education for renal care specialists and patients worldwide.  For more information visit www.genzyme.com or call 1.800.847.0069.

NxStage, Inc.
NxStage® Medical Inc. is a medical device company headquartered in Lawrence, Mass. that develops, manufactures, and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Over 2,200 home patients enjoy the freedom and flexibility of the System One™ hemodialysis machine, the first truly portable system indicated for home hemodialysis. In hospital ICUs, NxStage is the equipment of choice for 7 of the top 10 kidney disease hospitals (as ranked by US News & World Report). And, Medisystems, a NxStage company, is the market leader in tubing and access needle products in US dialysis centers.  Visit http://www.nxstage.com/ for more information.

National Renal Administrators Association (NRAA)
NRAA is a nonprofit organization representing professional managers of dialysis facilities and centers throughout the United States. NRAA members include renal administrators, nurse managers, nurses, medical directors, technicians and financial/billing managers for dialysis clinics, which provide life-sustaining dialysis care to the majority of Medicare End Stage Renal Disease (ESRD) patients. From a few charter members in 1977, NRAA has become a respected leader in the dialysis community and the only organization representing the operational concerns of dialysis facilities.
NRAA represents the interests of ALL facilities—hospital-based and freestanding, for-profit and non-profit, independent and chain, urban and rural. Through education, networking, information sharing, and governmental representation, NRAA strives to ensure competence and enhance professionalism throughout the renal community. he is a leading healthcare company with a uniquely broad spectrum of innovative solutions. Call 215-320-4655 or visit www.nraa.org for more information.

One Legacy
OneLegacy Transplant Donor Network is one of 58 regional non-profit, federally designated organizations dedicated to the life-saving and life-enhancing benefits of organ and tissue donation. Working together with the 14 transplant centers and 220 hospitals of Southern California, OneLegacy serves a diverse population of 18.3 million people in Los Angeles, Kern, Orange, Riverside, San Bernardino, Santa Barbara and Ventura counties.
We are nurses, healthcare professionals and community educators who believe passionately in the value of giving greater meaning to those whose lives are tragically cut short by helping children and adults live longer, fuller lives through transplantation.  Please visit www.onelegacy.org to learn more about us.

PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures.
PhRMA's mission is winning advocacy for public policies that encourage the discovery of life-saving and life enhancing new medicines for patients by pharmaceutical/biotechnology research companies. Visit www.phrma.org for more information.

Roche, Inc.
Roche is a leading healthcare company with a uniquely broad spectrum of innovative solutions. For more than 100 years, they have been active in the discovery, development, manufacture and marketing of novel healthcare solutions. Their products and services address prevention, diagnosis and treatment of diseases, thus enhancing well-being and quality of life. The focus is not just the diagnosis and treatment of manifest disease. The integrated healthcare approach is increasingly offering ways of identifying and targeting diseases early, when their damaging effects can still be prevented. Visit www.roche.com for more information.